SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-21-016172
Filing Date
2021-10-20
Accepted
2021-10-20 17:14:24
Documents
1
Period of Report
2021-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp160070_4-rsltd.html 4  
1 FORM 4 dp160070_4-rsltd.xml 4 5980
  Complete submission text file 0000950103-21-016172.txt   7785
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Reporting) CIK: 0001635088 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 211334874
SIC: 2834 Pharmaceutical Preparations